Gensan S.R.L.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes2 trials
• Chronic kidney disease1 trial
• Stroke1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Pfizer2 trials
• Eli Lilly and Company1 trial
• Novo Nordisk A/S1 trial

Running trials

• Not yet recruiting

  A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

  NCT07931495· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

  NCT07400653· Phase 3· Pfizer· Source

• Active, not recruiting

  Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

  NCT07311850· Phase 3· Pfizer· Source

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting